| 9.58 -0.2 (-2.05%) | 04-25 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.52 | 1-year : | 13.7 |
| Resists | First : | 10.71 | Second : | 11.72 |
| Pivot price | 9.82  |
|||
| Supports | First : | 9.08 | Second : | 7.55 |
| MAs | MA(5) : | 9.62  |
MA(20) : | 10.11 |
| MA(100) : | 8.66 |
MA(250) : | 9.74 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 33.2 |
D(3) : | 29.8 |
| RSI | RSI(14): 42.2 |
|||
| 52-week | High : | 15.36 | Low : | 6.36 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ AHCO ] has closed above bottom band by 32.5%. Bollinger Bands are 25.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.77 - 9.84 | 9.84 - 9.89 |
| Low: | 9.38 - 9.45 | 9.45 - 9.5 |
| Close: | 9.49 - 9.59 | 9.59 - 9.68 |
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Wed, 24 Apr 2024
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year? - Zacks Investment Research
Wed, 24 Apr 2024
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance UK
Tue, 23 Apr 2024
Do Options Traders Know Something About AdaptHealth (AHCO) Stock We Don't? - Yahoo Singapore News
Wed, 17 Apr 2024
AdaptHealth names Suzanne Foster as CEO (NASDAQ:AHCO) - Seeking Alpha
Tue, 09 Apr 2024
Upcoming Deadline to Share in AdaptHealth Corp. (AHCO) Class Action Settlement - TipRanks.com - TipRanks
Mon, 08 Apr 2024
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 133 (M) |
| Shares Float | 77 (M) |
| Held by Insiders | 17.4 (%) |
| Held by Institutions | 87.4 (%) |
| Shares Short | 8,210 (K) |
| Shares Short P.Month | 9,030 (K) |
| EPS | -5.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.32 |
| Profit Margin | -21.3 % |
| Operating Margin | 12.1 % |
| Return on Assets (ttm) | 3.3 % |
| Return on Equity (ttm) | -37.3 % |
| Qtrly Rev. Growth | 10 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 24.07 |
| EBITDA (p.s.) | 4.83 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 481 (M) |
| Levered Free Cash Flow | 176 (M) |
| PE Ratio | -1.81 |
| PEG Ratio | 0.8 |
| Price to Book value | 0.84 |
| Price to Sales | 0.39 |
| Price to Cash Flow | 2.64 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|